Nephros (NEPH)
(Delayed Data from NSDQ)
$1.79 USD
+0.04 (2.29%)
Updated Sep 25, 2024 03:35 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Nephros Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 14 | 10 | 10 | 9 | 10 |
Cost Of Goods | 6 | 5 | 5 | 4 | 4 |
Gross Profit | 8 | 5 | 6 | 5 | 6 |
Selling & Adminstrative & Depr. & Amort Expenses | 10 | 9 | 10 | 9 | 9 |
Income After Depreciation & Amortization | -2 | -4 | -4 | -4 | -3 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -2 | -4 | -4 | -5 | -3 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -2 | -4 | -4 | -5 | -3 |
Extras & Discontinued Operations | 0 | -3 | 0 | 0 | 0 |
Net Income (GAAP) | -2 | -7 | -4 | -5 | -3 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | -4 | -4 | -4 | -3 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -2 | -4 | -4 | -4 | -3 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 10.39 | 10.30 | 10.02 | 9.08 | 7.54 |
Diluted EPS Before Non-Recurring Items | -0.15 | -0.45 | -0.41 | -0.52 | -0.45 |
Diluted Net EPS (GAAP) | -0.15 | -0.73 | -0.41 | -0.52 | -0.45 |
Fiscal Year end for Nephros Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 3.25 | 3.52 | 3.25 | 3.74 | 3.55 |
Cost Of Goods | 1.34 | 1.34 | 1.23 | 1.55 | 1.47 |
Gross Profit | 1.91 | 2.19 | 2.02 | 2.19 | 2.08 |
SG&A, R&D, and Dept/Amort Expenses | 2.22 | 2.38 | 2.67 | 2.41 | 2.51 |
Income After SG&A, R&D, and Dept/Amort Expenses | -0.31 | -0.19 | -0.65 | -0.22 | -0.43 |
Non-Operating Income | 0.03 | 0.03 | 0.00 | 0.02 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -0.29 | -0.17 | -0.65 | -0.18 | -0.43 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -0.29 | -0.17 | -0.65 | -0.18 | -0.43 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -0.29 | -0.17 | -0.65 | -0.18 | -0.43 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 10.51 | 10.50 | 10.90 | 10.46 | 10.30 |
Diluted EPS Before Non-Recurring Items | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |
Diluted Net EPS (GAAP) | -0.03 | -0.02 | -0.06 | -0.02 | -0.04 |